参考文献
[1] 《中国血栓性疾病防治指南》专家委员会 . 中国血栓性疾病防治指南 [J]. 中华医学杂志,2018,98(36):2861-2888. DOI: 10.3760/cma.j.issn.0376-2491.2018.36.002.
[2] Desai J, Kolb JM, Weitz JI, et al. Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies[J]. Thromb Haemost, 2013,110(2):205-212. DOI: 10.1160/TH13-02-0150.
[3] Lanas A, García-Rodríguez LA, Arroyo MT, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations[J]. Gut, 2006,55(12):1731-1738. DOI: 10.1136/gut.2005.080754.
[4] Vaduganathan M, Bhatt DL. Gastrointestinal bleeding with oral anticoagulation: understanding the scope of the problem[J]. Clin Gastroenterol Hepatol, 2017,15(5):691-693. DOI: 10.1016/j.cgh.2016.12.033.
[5] Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Eur Heart J, 2021,42(14):1289-1367. DOI: 10.1093/eurheartj/ehaa575.
[6] Miller CS, Dorreen A, Martel M, et al. Risk of gastrointestinal bleeding in patients taking non-vitamin K antagonist oral anticoagulants: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2017,15(11):1674-1683.DOI: 10.1016/j.cgh.2017.04.031.
[7] Abraham NS, Noseworthy PA, Yao X, et al. Gastrointestinal safety of direct oral anticoagulants: a large population-based study[J]. Gastroenterology, 2017,152(5):1014-1022. DOI: 10.1053/j.gastro.2016.12.018.
[8] Gronich N, Stein N, Muszkat M. Association between use of pharmacokinetic-interacting drugs and effectiveness and safety of direct acting oral anticoagulants: nested case-control study[J]. Clin Pharmacol Ther, 2021[online ahead of print].DOI: 10.1002/cpt.2369.
[9] Kyaw MH, Chan F. Managing antithrombotic agents in the setting of acute gastrointestinal bleeding[J]. Gastrointest Endosc Clin N Am, 2018,28(3):351-361. DOI: 10.1016/j.giec.2018.02.007.
[10] Steffel J, Verhamme P, Potpara TS, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of nonvitamin K antagonist oral anticoagulants in patients with atrial fibrillation[J]. Eur Heart J, 2018,39(16):1330-1393. DOI: 10.1093/eurheartj/ehy136.
[11] CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee[J]. Lancet,1996,348(9038):1329-1339. DOI: 10.1016/s0140-6736(96)09457-3.
[12] Tsai TJ, Lai KH, Hsu PI, et al. Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy[J]. J Formos Med Assoc, 2012,111(12):705-710. DOI: 10.1016/j.jfma.2011.11.028.
[13] Koo BK, Kang J, Park KW, et al. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial[J]. Lancet, 2021,397(10293):2487-2496. DOI: 10.1016/S0140-6736(21)01063-1.
[14] García Rodríguez LA, Lin KJ, Hernández-Díaz S, et al. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications[J]. Circulation, 2011,123(10):1108-1115. DOI: 10.1161/CIRCULATIONAHA.110.973008.
[15] Lai KC, Chu KM, Hui WM, et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications[J]. Clin Gastroenterol Hepatol, 2006,4(7):860-865. DOI: 10.1016/j.cgh.2006.04.019.
[16] Guo CG, Chen L, Chan EW, et al. Systematic review with meta-analysis: the risk of gastrointestinal bleeding in patients taking third-generation P2Y12 inhibitors compared with clopidogrel[J]. Aliment Pharmacol Ther, 2019,49(1):7-19. DOI: 10.1111/apt.15059.
[17] 周春华 , 赵九龙 , 方雪 , 等 . 华法林相关消化道出血的临床特点及预防治疗策略 [J]. 中华内科杂志,2018,57(6):469-472. DOI: 10.3760/cma.j.issn.0578-1426.2018.06.017.
[18] Guo WQ, Chen XH, Tian XY, et al. Differences in gastrointestinal safety profiles among novel oral anticoagulants: evidence from a network meta-analysis[J]. Clin Epidemiol, 2019,11:911-921. DOI: 10.2147/CLEP.S219335.
[19] Aisenberg J, Chatterjee-Murphy P, Friedman Flack K, et al. Gastrointestinal bleeding with edoxaban versus warfarin: results from the ENGAGE AF-TIMI 48 trial (effective anticoagulation with factor Xa next generation in atrial fibrillation-thrombolysis in myocardial infarction)[J]. Circ Cardiovasc Qual Outcomes, 2018,11(5):e003998. DOI: 10.1161/CIRCOUTCOMES.117.003998.
[20] Yamashita T, Koretsune Y, Yang Y, et al. Edoxaban vs. warfarin in East Asian patients with atrial fibrillation-an ENGAGE AF-TIMI 48 subanalysis[J]. Circ J,2016,80(4):860-869. DOI: 10.1253/circj.CJ-15-1082.
[21] Lee SR, Choi EK, Han KD, et al. Edoxaban in Asian patients with atrial fibrillation: effectiveness and safety[J]. J Am Coll Cardiol, 2018,72(8):838-853. DOI: 10.1016/j.jacc.2018.05.066.
[22] 中华医学会消化病学分会幽门螺杆菌和消化性溃疡学组 , 刘文忠 , 谢勇 , 等 . 第五次全国幽门螺杆菌感染处理共识报告 [J]. 中华内科杂志 ,2017,56(7):532-545. DOI:10.3760/cma.j.issn.0578-1426.2017.07.014.
[23] Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)[J]. Eur Heart J, 2018,39(3):213-260. DOI: 10.1093/eurheartj/ehx419.
[24] Eikelboom JW, Connolly SJ, Bosch J, et al. Bleeding and new cancer diagnosis in patients with atherosclerosis[J]. Circulation, 2019,140(18):1451-1459. DOI: 10.1161/CIRCULATIONAHA.119.041949.
[25] 中国医师协会心血管内科医师分会血栓防治专业委员会 , 中华医学会心血管病学分会介入心脏病学组 , 中华心血管病杂志编辑委员会 . 急性冠状动脉综合征特殊人群抗血小板治疗中国专家建议[J].中华心血管病杂志,2018,46(4):255-266. DOI: 10.3760/cma.j.issn.0253-3758.2018.04.003.
[26] 霍勇,王拥军,谷涌泉,等 . 常用口服抗血小板药物不耐受及低反应性人群诊疗专家共识 [J/OL]. 中华心血管病杂志( 网 络 版 ),2021,4:e1000076.(2021-05-21)[2021-06-20].http://www.cvjc.org.cn/index.php/Column/columncon/article_id/244. DOI:10.3760/cma.j.cn116031.2021.1000076.
[27] Lanas Á, Carrera-Lasfuentes P, Arguedas Y, et al. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants[J]. Clin Gastroenterol Hepatol, 2015,13(5):906-912.DOI:10.1016/j.cgh.2014.11.007.
[28] Wang ZY, Chen M, Zhu LL, et al. Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy[J]. Ther Clin Risk Manag, 2015,11:449-467. DOI: 10.2147/TCRM.S80437.
[29] Oakland K, Chadwick G, East JE, et al. Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology[J]. Gut, 2019,68(5):776-789. DOI: 10.1136/gutjnl-2018-317807.
[30] Stanley AJ, Laine L. Management of acute upper gastrointestinal bleeding[J]. BMJ, 2019,364:l536. DOI: 10.1136/bmj.l536.
[31] 国家卫生健康委员会脑卒中防治专家委员会房颤卒中防治专业委员会 , 中华医学会心电生理和起搏分会 , 中国医师协会心律学专业委员会 . 达比加群特异性逆转剂依达赛珠单抗的临床应用专家共识 [J]. 中华心律失常学杂志 ,2020,24(2):113-122. DOI: 10.3760/cma.j.cn.113859-20200 309-00057.
[32] Connolly SJ, Crowther M, Eikelboom JW, et al. Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors[J]. N Engl J Med, 2019,380(14):1326-1335. DOI: 10.1056/NEJMoa1814051.
[33] Tomaselli GF, Mahaffey KW, Cuker A, et al. 2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Solution Set Oversight Committee[J]. J Am Coll Cardiol, 2020,76(5):594-622. DOI: 10.1016/j.jacc.2020.04.053.
[34] Laursen SB, Oakland K, Laine L, et al. ABC score: a new risk score that accurately predicts mortality in acute upper and lower gastrointestinal bleeding: an international multicentre study[J]. Gut, 2021,70(4):707-716. DOI: 10.1136/gutjnl-2019-320002.
[35] 中华消化杂志编辑委员会 , 中华消化外科杂志编辑委员会 . 急性非静脉曲张性上消化道出血多学科防治共识 [J].中华消化杂志 ,2019,39(12):793-799. DOI: 10.3760/cma.j.issn.0254-1432.2019.12.001.
[36] Gralnek IM, Stanley AJ, Morris AJ, et al. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) guideline - update 2021[J]. Endoscopy, 2021,53(3):300-332. DOI: 10.1055/a-1369-5274.
[37] 中国医师协会急诊医师分会 , 中华医学会急诊医学分会 , 全军急救医学专业委员会 , 等 . 急性上消化道出血急诊诊治流程专家共识 [J]. 中国急救医学 , 2021,41(1): 1-10.DOI:10.3969/j.issn.1002-1949.2021.01.001.
[38] Sostres C, Marcén B, Laredo V, et al. Risk of rebleeding, vascular events and death after gastrointestinal bleeding in anticoagulant and/or antiplatelet users[J]. Aliment Pharmacol Ther, 2019,50(8):919-929. DOI: 10.1111/apt.15441.
[39] Scott MJ, Veitch A, Thachil J. Reintroduction of antithrombotic therapy after a gastrointestinal haemorrhage: if and when?[J]. Br J Haematol, 2017,177(2):185-197. DOI: 10.1111/bjh.14599.
[40] Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding[J]. Lancet, 1974,2(7877):394-397. DOI: 10.1016/s0140-6736(74)91770-x.
[41] Aoki T, Hirata Y, Yamada A, et al. Initial management for acute lower gastrointestinal bleeding[J]. World J Gastroenterol, 2019,25(1):69-84. DOI: 10.3748/wjg.v25.i1.69.
[42] Okumura K, Akao M, Yoshida T, et al. Low-dose edoxaban in very elderly patients with atrial fibrillation[J]. N Engl J Med, 2020,383(18):1735-1745. DOI: 10.1056/NEJMoa2012883.